Mayordoma, Reyname A.
HRN: 20-37-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2024
CLINDAMYCIN 300MG (CAP)
06/22/2024
06/28/2024
PO
300mg
TID
Post Excision Of Perineal Mass
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes